DIVERSIFIED HEALTHCARE TRUST (DHC)
Real Estate · Healthcare REITs · NASDAQ
Diversified Healthcare Trust is a REIT focused on owning and operating a broad portfolio of senior living, medical office, and life science real estate properties across the U.S.
What DIVERSIFIED HEALTHCARE TRUST does
Diversified Healthcare Trust is a real estate investment trust (REIT) that owns a portfolio of healthcare-related properties throughout the United States. The company's assets consist primarily of senior living communities and life science, medical office, and biotech laboratory properties. It generates revenue through property rentals and the provision of resident fees and services at its managed healthcare facilities.
Themes: healthcare real estate, senior living, life sciences infrastructure, biotech real estate
Fundamentals
- Price$7.55 as of 2026-10-08 close
- Market cap$1.8B as of 2026-07-31 (share count; price 2026-10-08)
- 1-year return+77.6% 2025-10-08 close $4.25 → 2026-10-08 close $7.55
- P/En/a negative earnings
- Net margin-18.6% FY2025, SEC XBRL
- ROE-17.2% FY2025, SEC XBRL
- Debt / equity1.52 as of 2026-09-03
- Revenue growth (YoY)-1.5% as of 2026-09-03
- Revenue CAGR (3y)+6.2% SEC XBRL
- Beta0.73 as of 2026-09-03
- Last reported earnings2026-08-03 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +0.5%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
How DHC compares in its sector
- net profit marginbottom 10% 154 covered Real Estate peers, as of 2026-09-03
- return on equitybottom 10% 158 covered Real Estate peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 155 covered Real Estate peers
- indicated dividend yieldbottom 10% 140 covered Real Estate peers, as of 2026-09-03
Position among covered Real Estate companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
DHC is not currently in any published Top 10 list. Its scores are below.
Top 10 score
47.3 #612 of 991 scored · #53 of 85 in Real Estate
Valuation 98th (price to book 0.7) and trend 72nd (over the past 12 months this stock beat the market by 125.9 percentage points); weakest is profitability (2nd, operating margin -9.5%, return on equity -16.2%).
Scores as of 18 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 1. DHC was not in the scored universe at the latest run on 8 Oct 2026, so these scores are its last ones.
Dividend coverage (FY2025)
Not assessable from available data. DHC paid a dividend in FY2025, but coverage cannot be assessed from the available data (non_positive_net_income, non_positive_operating_cash_flow).
- Earnings payoutnot assessable earnings were not positive that year
- Free-cash-flow payoutnot assessable operating cash flow was not positive that year
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How DIVERSIFIED HEALTHCARE TRUST looks technically
DIVERSIFIED HEALTHCARE TRUST (DHC) is trading 1.1% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 323 trading days ago — a "golden cross", a bullish long-term signal. A trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 21 (a reading of 25+ marks a strong trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 4 trading days ago (its momentum flipped negative). It made a new 20-day high about 13 trading days ago. It is 21.8% below its highest point of the past year.
Trend
8
| Distance from the 200-day | it is trading 1.1% above its 200-day average, the long-term trend line — a longer-term uptrend | +1.1% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $8.03 | $8.03 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $7.47 | $7.47 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 16 calendar days ago — the swings before that are what the structure reading is measured on | 16 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five; the labelling fails if price closes above 8.28. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 5 (atypical proportions) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 323 trading days ago — a "golden cross", a bullish long-term signal | 323 sessions |
| Trend strength (14-day ADX) | a trend is forming but not yet strong — ADX, a 0–100 trend-strength gauge, is 21 (a reading of 25+ marks a strong trend) | 21.0 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 36, neither overbought (above 70) nor oversold (below 30) | 36.3 |
|---|---|---|
| Position in its 14-day range | it is trading near the bottom of its 14-day range ($7.39 to $8.28) — its "stochastic" reading is 18 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 18.0 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 4 trading days ago (its momentum flipped negative) | 4 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $9.66 | $9.66 |
|---|---|---|
| From the 52-week high | it is 21.8% below its 52-week high (its highest price of the past year) | -21.8% |
| Above the 52-week low | it is 92.6% above its 52-week low (its lowest price of the past year) | +92.6% |
| Below the 52-week high | it is 21.8% below its highest point of the past year | 21.8% |
| Since a 20-day breakout | it made a new 20-day high about 13 trading days ago | 13 sessions |
| Since a 55-day breakout | it made a new 55-day low about 20 trading days ago | 20 sessions |
| All-time high | its highest closing price on record is $29.99 (set on 2013-05-22) | $29.99 |
| Given back of the 52-week move | over the past year its closes ranged ($4.05 to $9.64), and it has given back roughly a third of its rise from last year’s low — 37% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $6.01 to $6.19. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 37.4% |
| From the all-time high | it is 74.8% below its all-time high | -74.8% |
| Nearest price level | it is trading 1.1% below a resistance level at $7.64 — a price it turned at twice since 2026-03-04, most recently on 2026-03-12. Since 2024-10-08 it has 12 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +1.1% |
| All-time low | its lowest closing price on record is $0.61 (set on 2022-12-22) | $0.61 |
| Above the all-time low | it is 1137.7% above its all-time low | +1,138% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 74% of it) | 26th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.2422 between its high and its low — about 3.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.2422 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $7.39 and $8.32 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $7.39 – $7.86 – $8.32 |
| Typical daily range (% of price) | its price moves about 3.2% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 3.2% |
| Stretch from the 200-day average | it is trading 0.3 daily ranges above its 200-day average price (1.1% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.3 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 1.10× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a doji | 2 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 2 sessions ago |
|---|---|---|
| Since a bullish engulfing | today it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | today |
Price gaps
2
| Gap at the open | it opened on 2026-10-08 0.5% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.5% |
|---|---|---|
| Gap filled | a 4.5% gap down opened on 2026-08-17 has been "filled" 37 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 37 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 1.7 percentage points (the stock lost 0.7% while the market gained 1.0%) | -1.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 20.2 percentage points (the stock lost 16.4% while the market gained 3.8%) | -20.2% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 9.4 percentage points (the stock gained 8.0% while the market gained 17.5%) | -9.4% |
| vs market, 12 months | over the past 12 months this stock beat the market by 62.7 percentage points (the stock gained 77.6% while the market gained 15.0%) | +62.7% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, near the bottom of its 14-day range (oversold) — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: MACD momentum is negative, lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 7.8% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 5.2% of the share price. | -7.8% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 1% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $7.63 — a volume-weighted average of daily closes over 187 sessions, not a true tick-by-tick VWAP. | -1.1% |
|---|---|---|
| Vs the average paid since it last reported | the price is 6% below the average price paid since it last reported on 2026-08-03 (its 10-Q), so the typical buyer over that stretch is under water. That average is $8.05 — a volume-weighted average of daily closes over 48 sessions, not a true tick-by-tick VWAP. | -6.3% |
Price levels it has turned at before
DHC last closed at $7.55 on 2026-10-08. Since 2024-10-08 it has turned at 12 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $7.64 | Resistance | 1.1% above the last close | turned there twice · 2026-03-04 to 2026-03-12 |
| $7.46 | Support | 1.2% below the last close | turned there twice · 2026-04-16 to 2026-09-04 |
| $6.88 | Support | 8.8% below the last close | turned there twice · 2026-02-18 to 2026-04-23 |
| $9.66 | Resistance | 27.9% above the last close | turned there twice · 2026-06-30 to 2026-07-22 |
| $4.63 | Support | 38.6% below the last close | turned there twice · 2025-12-11 to 2025-12-29 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five.
This labelling fails — stops being a possible reading at all — if it closes above $8.28.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 3 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $6.68 and $7.67 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 8 trading days, since 2026-09-29.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Near 200-day moving-average support · Trading above the 200-day moving average · Pulled back from the 12-month high · MACD just crossed bearish (12/26/9) · lagging the market · Printed a bullish engulfing pair | Learn: moving average · golden cross · adx · rsi · macd · breakout · fifty two week high low
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$10.15 range $8.00 – $11.50; median $10.55
Analyst estimates, as of 2026-10-08. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for DHC
- Consensus EPS estimate-$0.13 next reporting period, as of 2026-10-08
- Estimate change, 30 days$0.00 from -$0.13, on 2026-09-03, 35-day window
- Readings revised upward0% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Significant debt obligations and potential challenges in refinancing or debt modification.","Historical net losses and ongoing dependency on operational performance in the senior living sector.","Exposure to fluctuations in property operating expenses and healthcare service costs."]
What changed in the latest 10-Q
AI-assisted comparison of DHC's 10-Q filed 2026-08-03 against the prior one filed 2026-05-04.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing reports portfolio data for the three and six months ended June 30, 2026 and 2025, whereas the older filing reports data for the three months ended March 31, 2026 and 2025 (newer filing does not include the six-month table from the older filing's period format but includes both three and six month tables for the June 30 periods).
- Newer filing reports 'Number of units' for SHOP All Properties as of June 30, 2026 as 22,469 units (older filing reported 22,573 units as of March 31, 2026).
- Newer filing reports SHOP All Properties occupancy of 82.5% for the three months ended June 30, 2026 and 80.6% for 2025 (older filing reported 81.7% and 80.2% for the three months ended March 31, 2026 and 2025).
- Newer filing reports Medical Office and Life Science Portfolio All Properties occupancy of 92.2% for the three months ended June 30, 2026 and 82.9% for 2025 (older filing reported 91.8% and 80.6% for the three months ended March 31, 2026 and 2025).
- Newer filing reports rent coverage for triple net leased senior living communities of 2.19x (comparable) and 2.22x (all properties) (older filing reported 1.84x for both).
- Newer filing reports rent coverage for wellness centers of 3.32x (both comparable and all properties) (older filing reported 3.09x for both).
- Newer filing reports weighted average rent coverage of 2.78x (both comparable and all properties) (older filing reported 2.49x for both).
- Newer filing includes a six-month operating metrics table (six months ended June 30, 2026 and 2025) that was not present in the older filing.
- Removed:
- Older filing reported an average remaining lease term of 13.9 years for Seaport JV and LSMD JV (newer filing reports 13.6 years).
- Older filing included a table of new and renewal leases in the Medical Office and Life Science Portfolio segment for the three months ended March 31, 2026, which is not present in the newer filing.
- Reworded:
- Newer filing's portfolio overview for the three months ended June 30, 2026 shows 'Gross Book Value of Real Estate Assets' for SHOP of $4,409,401 thousand versus older filing's $4,375,739 thousand for the three months ended March 31, 2026.
- Newer filing shows Medical Office and Life Science Portfolio gross book value of real estate assets of $1,489,557 thousand versus older filing's $1,491,588 thousand.
- Newer filing shows Total gross book value of real estate assets of $6,262,230 thousand versus older filing's $6,230,599 thousand.
- Newer filing shows SHOP NOI of $53,495 thousand (63.4% of NOI) for the three months ended June 30, 2026 versus older filing's $43,626 thousand (57.5% of NOI) for the three months ended March 31, 2026.
- Newer filing shows Medical Office and Life Science Portfolio NOI of $23,709 thousand (28.1% of NOI) versus older filing's $25,064 thousand (33.0% of NOI).
- Newer filing shows Triple net leased senior living communities NOI of $3,446 thousand (4.1% of NOI) versus older filing's $3,440 thousand (4.5% of NOI).
- Newer filing shows Wellness centers NOI of $3,793 thousand (4.4% of NOI) versus older filing's $3,785 thousand (5.0% of NOI).
- Newer filing shows Total NOI of $84,443 thousand versus older filing's $75,915 thousand.
- Newer filing reports SHOP comparable properties occupancy of 83.1% for the three months ended June 30, 2026 and 81.5% for 2025 (older filing reported 82.4% and 81.3% for the three months ended March 31, 2026 and 2025).
- Newer filing reports SHOP comparable properties average monthly rate of $5,715 for 2026 and $5,380 for 2025 (older filing reported $5,656 and $5,341).
- Newer filing reports SHOP all properties average monthly rate of $5,693 for 2026 and $5,440 for 2025 (older filing reported $5,613 and $5,413).
- Newer filing reports Medical Office and Life Science Portfolio comparable properties occupancy of 95.8% for 2026 and 94.7% for 2025 (older filing reported 95.3% and 94.7% for the three months ended March 31, 2026 and 2025).
- Newer filing reports Medical Office and Life Science Portfolio all properties total square feet for 2025 of 7,400,023 (older filing reported 7,619,667).
- Newer filing shows SHOP all properties count of 199 versus 230 for the three months ended June 30, 2026 and 2025 (older filing showed 199 versus 231 for the three months ended March 31, 2026 and 2025).
- Newer filing shows Medical Office and Life Science Portfolio all properties count of 67 versus 92 for the three months ended June 30, 2026 and 2025 (older filing showed 67 versus 93 for the three months ended March 31, 2026 and 2025).
- Newer filing shows SHOP all properties number of units for 2025 of 24,872 (older filing reported 25,005).
- Newer filing's footnote (1) to comparable properties describes properties owned, in service and reported in the same segment since April 1, 2025 for the three months ended June 30, 2026 and January 1, 2025 for the six months ended June 30, 2026, whereas older filing's footnote (1) describes properties owned, in service and reported in the same segment and leased to the same operator continuously since January 1, 2025.
- Newer filing's rent coverage footnote removes the comparative rent coverage data explanation wording found in the older filing (no wording change identified in the older text; the newer text is truncated at the end).
- Notes:
- The newer filing text appears truncated at the end ('During the three and six months ended June 30' with no continuation), so any content after that point in the newer filing cannot be compared.
- The older filing text appears truncated at the end ('As of March 31, 2026, lease expirations in our Medical Office and Life Science Portfolio segment were as' with no continuation), so any content after that point in the older filing cannot be compared.
Risk Factors
- Reworded:
- In the newer filing (filed 2026-08-03), the share repurchase table covers the three months ended June 30, 2026 with rows for April 1-30, 2026 (1,706 shares at $6.92) and June 1-30, 2026 (4,380 shares at $8.87), totaling 6,086 shares at a weighted average of $8.32; in the older filing (filed 2026-05-04), the table covers the three months ended March 31, 2026 with a single row for March 1-31, 2026 (12,393 shares at $7.15), totaling 12,393 shares at $7.15.
- In the newer filing (filed 2026-08-03), footnote (1) states fair market values were based upon 'the trading prices of our common shares at the close of trading on Nasdaq on the applicable purchase dates'; in the older filing (filed 2026-05-04), footnote (1) states fair market values were based upon 'the trading price of our common shares at the close of trading on Nasdaq on the purchase date'.
- In the newer filing (filed 2026-08-03), exhibit 3.5 is described as 'Fourth Amended and Restated By laws of the Company'; in the older filing (filed 2026-05-04), exhibit 3.5 is described as 'Fourth Amended and Restated Bylaws of the Company'.
- In the newer filing (filed 2026-08-03), exhibit 22.1 reference reads 'the Company's Annual Report on Form 10-K for the year ended December 31, 2025'; in the older filing (filed 2026-05-04), exhibit 22.1 reference reads 'the Company's Annual Report on Form 10- K for the year ended December 3 1 , 2025'.
- Notes:
- The provided texts include Item 2 (Unregistered Sales of Equity Securities and Use of Proceeds) and Item 6 (Exhibits) in addition to the Risk Factors section; the Risk Factors statement itself is identical in both filings.
- The newer filing's Item 6 exhibit list appears truncated at the end; no changes beyond the truncation point could be assessed.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-04. The 5 days since 2026-10-04 have not been checked yet.
Most recent open-market transaction: 2025-12-15. Based on Form 4 filings read through 2026-10-04; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about DHC's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Short interest (FINRA)
DHC had 13,414,390 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
DHC had 5.54% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 8.4 days to cover at the same settlement.
- Reported short interest (shares) 13,414,390
- Short interest (% of shares outstanding) 5.54%
- Prior settlement (shares) 12,922,023
- Reported change 3.81%
- Days to cover (reported) 8.4
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- Welltower (WELL)
- Ventas (VTR)
- Healthpeak Properties
- Omega Healthcare Investors (OHI)
- Sabra Health Care REIT (SBRA)
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare DHC vs…
DIVERSIFIED HEALTHCARE TRUST is found in…
Frequently asked questions
What does DIVERSIFIED HEALTHCARE TRUST (DHC) do?
Diversified Healthcare Trust is a real estate investment trust (REIT) that owns a portfolio of healthcare-related properties throughout the United States. The company's assets consist primarily of senior living communities and life science, medical office, and biotech laboratory properties. It generates revenue through property rentals and the provision of resident fees and services at its managed healthcare facilities.
What sector is DIVERSIFIED HEALTHCARE TRUST (DHC) in?
DIVERSIFIED HEALTHCARE TRUST (DHC) is classified in the Real Estate sector. Its industry is Healthcare REITs. It trades on NASDAQ.
Does DHC pay a dividend?
Yes — DIVERSIFIED HEALTHCARE TRUST (DHC) pays a dividend, with an indicated yield of about 0.50% and 5-year non-decreasing per-share dividend streak (SEC EDGAR XBRL) (market data, as of 2026-09-03). Informational only — not financial advice.
Who are DIVERSIFIED HEALTHCARE TRUST's (DHC) competitors?
Notable peers of DIVERSIFIED HEALTHCARE TRUST (DHC) include Welltower, Ventas, Healthpeak Properties, Omega Healthcare Investors and Sabra Health Care REIT. This peer set is informational only — not financial advice.
Is DIVERSIFIED HEALTHCARE TRUST (DHC) overbought or oversold right now?
DIVERSIFIED HEALTHCARE TRUST (DHC) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 36, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on DHC come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.